Sumedha B S, Bangalore University The novel human coronavirus, SARS-CoV-2 has created a global disease burden infecting>100 million humans in just over a year. It has become a major challenge to the health system worldwide. Detection is very crucial in this pandemic. Studies have shown that early detection is very necessary for disease control. Currently, […]
Debarati Basu, Makaut WB Vaccines derived from mRNA have greater versatility and efficacy for preventing Covid-19 infections. An effective alternative is DNA vaccines. It is used as it can induce humoral and cellular immune responses in animal models. They can also be utilized in human trials. The efficacy and immunogenicity of DNA-based vaccines were tested. […]
Sayak Banerjee, Amity University Kolkata Out of all the vaccine-making companies, Bharat Biotech is the only one to locally develop a vaccine in India and result in large-scale manufacturing. The manufacturing of Covaxin had been started at Ankleshwar, Gujarat before which equipment efficacy was studied by carrying out engineering batches. After a 120-day timeline for manufacturing, testing, release, regulatory […]
Aqsa, Jamia Millia Islamia The ongoing Covid-19 pandemic is still unlocking many unknown facts about it. With every new strain, different symptoms and post symptoms are still underway of getting understood. One such post covid symptom is reduced intelligence. To understand the possible cognitive consequences of COVID-19, a study on people who recovered from Covid […]
Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University Many biochemical processes have been described for the detection of antigens. These processes have high specificity, have high reproducibility, and are trustworthy. Several new biochemical processes are being developed with even better sensitivity. However, the downside of biochemical processes is that they are slow and require specialized […]
Saptaparna Dasgupta, Bennett University The COVID-19 vaccine has been created as an emergency vaccine, based on several strategies, such as mRNA vaccine, inactivated virus vaccine, etc. The other vaccines having cleared the clinical trials have passed on to the mass population vaccination drives, without any reported risk factors, yet. However, Johnson and Johnson’s COVID 19 […]
Camelia Bhattacharyya, Amity University Kolkata The coronavirus disease or COVID is something that is shaking the entire portrait of the lives of people in the world right now. This single-stranded, positive-sensed, enveloped virus has given rise to a pandemic in the 21st century. In such a situation, learning about the different mutants, variants, and strains […]
Saptaparna Dasgupta, Bennett University The risk of COVID19 infection is exceeded in multiple myeloma patients. Vaccine for the general population with BNT162b2 mRNA COVID19 (BNT162b2) provides effective protection against COVID19. However, their efficacy on patients with multiple myeloma may be adversely affected by and not yet assessed due to factors related to disease and therapy. […]
Neha khan, Jamia Millia Islamia What is the alpha variant? The B.1.1.7 variant is known as the Alpha variant which was first found in India and had taken thousands of lives. This coronavirus variant is more infectious than other variants because it foils the innate immune system for a while till it replicates and finds […]
Sribas Chowdhury, Adamas University Kolkata We all know how the horrific Covid19 pandemic has shaken the entire world. With the SARS-corona virus, 2 is the main culprit, it has claimed millions of lives worldwide and has disrupted the socio-economic balance of all countries. The virus has been a cause of concern due to its variants […]
